Correlates of Healthy Aging in Geriatric HIV (CHANGE HIV)-CTN 314
- PMID: 36851731
- PMCID: PMC9968122
- DOI: 10.3390/v15020517
Correlates of Healthy Aging in Geriatric HIV (CHANGE HIV)-CTN 314
Abstract
The Correlates of Healthy Aging in Geriatric HIV (CHANGE HIV) study, CTN 314, is the first Canadian cohort of people living with HIV aged 65 years and older. The cohort was established with the purpose of characterizing the multidimensional health status of this population and identifying factors influencing healthy aging. The study builds on the World Health Organization (WHO) Aging and Health conceptual framework, generating a comprehensive profile of health domains (physical, social, mental health, cognitive function, and quality of life), health determinants (biologic, personal, and environmental), and HIV-specific factors that may interact with and influence health in people aging with HIV. The data for the first 353 participants are presented, focusing on sociodemographic factors, comorbidities, coinfections, frailty, cognitive function, loneliness, and resilience using a sex/gender stratified analysis. The cohort thus far is 91% men and the median age is 70 years (range from 65 to 85). Several vulnerabilities were observed, including a high prevalence of comorbidities and frailty. Women especially faced financial insecurity and precarious social structures; a large proportion live alone and only 6% are married or in steady relationships. Identifying strategies to address these vulnerabilities will empower people aging with HIV to optimize their health, quality of life, and independence.
Keywords: HIV/AIDS; aging; cohort; health.
Conflict of interest statement
The authors declare no conflict of interest related to this research.
Figures
References
-
- Trickey A., May M.T., Vehreschild J.-J., Obel N., Gill M.J., Crane H.M., Boesecke C., Patterson S., Grabar S., Cazanave C., et al. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. Lancet HIV. 2017;4:e349–e356. doi: 10.1016/S2352-3018(17)30066-8. - DOI - PMC - PubMed
-
- Public Health Agency of Canada Estimates of HIV Incidence, Prevalence and Canada’s Progress on Meeting the 90–90–90 HIV Targets. 2020. [(accessed on 10 December 2022)]. Available online: https://www.canada.ca/en/public-health/services/publications/diseases-co....
-
- Public Health Agency of Canada HIV in Canada: 2021 Surveillance Highlights. [(accessed on 10 December 2022)]. Available online: https://www.canada.ca/en/public-health/services/publications/diseases-co....
-
- Samji H., Cescon A., Hogg R.S., Modur S.P., Althoff K., Buchacz K., Burchell A.N., Cohen M., Gebo K.A., Gill M.J., et al. Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada. PLoS ONE. 2013;8:e81355. doi: 10.1371/journal.pone.0081355. - DOI - PMC - PubMed
-
- Beard J.R., Officer A., De Carvalho I.A., Sadana R., Pot A.M., Michel J.P., Lloyd-Sherlock P., Epping-Jordan J.E., Peeters G.G., Mahanani W.R., et al. The World report on ageing and health: A policy framework for healthy ageing. Lancet. 2016;387:2145–2154. doi: 10.1016/S0140-6736(15)00516-4. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
